Nirsevimab Linked to Lower Infant Hospitalization Risk Than Maternal Vaccine - Quiz - MDSpire

Nirsevimab Linked to Lower Infant Hospitalization Risk Than Maternal Vaccine

First real-world comparison shows lower hospitalization and severe illness rates with infant immunization vs maternal vaccination.

  • By

  • Andrea Surnit

  • April 24, 2026

  • 3 min

Share

Original Source(s)

Nirsevimab Linked to Lower Infant Hospitalization Risk Than Maternal Vaccine

  • by Andrea Surnit

  • April 24, 2026

Related Content

FDA Clears Home Urine Collection Kit for STI Testing

The clearance enables a validated mail-in workflow for self-collected urine specimens processed on Roche cobas systems.

Side Effects: Nobody Trained for This

Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.

Beta-2 Agonists Tied to ASD Risk?

Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.